Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study

Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study

Abstract Background and objectives Patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombosis (PVTT) are presently lacking effective treatment options. We aimed to compare the efficacy and safety of lenvatinib with or without SBRT for HCC with PVTT. Materials and methods Thi...

Full description

Bibliographic Details
Main Authors: Xiaoquan Ji, Zhe Xu, Jing Sun, Wengang Li, Xuezhang Duan, Quan Wang
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Radiation Oncology
Subjects:
Hepatocellular carcinoma
Portal vein tumor thrombosis
Stereotactic body radiotherapy
Lenvatinib
Online Access:https://doi.org/10.1186/s13014-023-02270-z

Similar Items

Similar Items